Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Thomas Alonzo D


  • Acting President And Ceo at Salix Pharmaceuticals Ltd (SLXP), 2015-04-03
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
SLXP $29.77 580 Director 1,080 2011-08-11 Filing
SLXP $29.45 110 Director 69,340 2011-08-11 Filing
SLXP $44.80 500 Director 500 2010-12-01 Filing
SLXP $38.00 260 Director 260 2010-10-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SLXP $112.54 1,800 Director 79,179 2014-04-22 Filing
SLXP $111.30 3,300 Director 80,979 2014-04-22 Filing
SLXP $110.22 6,430 Director 84,279 2014-04-22 Filing
SLXP $92.85 50 Director 97,974 2014-01-10 Filing
SLXP $91.83 12,000 Director 98,024 2014-01-10 Filing